Advances in the development of TRPV1 antagonists

Bibliography

• SZOLCSANYI J: Forty years in capsaicin research for sensory pharmacology and physiology. Neuropeptides (2004) 38:377-384.
   PubMed Web of Science ®Google Scholar
• CATERINA MJ, SCHUMACHER MA, TOMINAGA M, ROSEN TA, LEVINE JD, JULIUS D: The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature (1997) 389:816-824.
   PubMed Web of Science ®Google Scholar
• DAVIS JB, GRAY J, GUNTHORPE MJ et al.: Vanilloid receptor-1 is essential for inflammatory thermal hyperalgesia. Nature (2000) 405:183-187.
   PubMed Web of Science ®Google Scholar
• CATERINA MJ, LEFFLER A, MALMBERG AB et al.: Impaired nociception and pain sensation in mice lacking the capsaicin receptor. Science (2000) 288:306-313.
   PubMed Web of Science ®Google Scholar
• TOMINAGA M, CATERINA MJ, MALMBERG AB et al.: The cloned capsaicin receptor integrates multiple pain-producing stimuli. Neuron (1998) 21:531-543.
   PubMed Web of Science ®Google Scholar
• BHAVE G, ZHU W, WANG H, BRASIER DJ, OXFORD GS, GEREAU RWT: cAMP-dependent protein kinase regulates desensitization of the capsaicin receptor (VR1) by direct phosphorylation. Neuron (2002) 35:721-731.
   PubMed Web of Science ®Google Scholar
• MOHAPATRA DP, NAU C: Desensitization of capsaicin-activated currents in the vanilloid receptor TRPV1 is decreased by the cyclic AMP-dependent protein kinase pathway. J. Biol. Chem. (2003) 278:50080-50090.
   PubMed Web of Science ®Google Scholar
• NUMAZAKI M, TOMINAGA T, TOYOOKA H, TOMINAGA M: Direct phosphorylation of capsaicin receptor VR1 by protein kinase Cepsilon and identification of two target serine residues. J. Biol. Chem. (2002) 277:13375-13378.
   PubMed Web of Science ®Google Scholar
• JUNG J, SHIN JS, LEE SY et al.: Phosphorylation of vanilloid receptor 1 by Ca2+/calmodulin-dependent kinase II regulates its vanilloid binding. J. Biol. Chem. (2004) 279:7048-7054.
   PubMed Web of Science ®Google Scholar
• NAGY I, SANTHA P, JANCSO G, URBAN L: The role of the vanilloid (capsaicin) receptor (TRPV1) in physiology and pathology. Eur. J. Pharmacol. (2004) 500:351-369.
   PubMed Web of Science ®Google Scholar
• GUO A, VULCHANOVA L, WANG J, LI X, ELDE R: Immunocytochemical localization of the vanilloid receptor 1 (VR1): relationship to neuropeptides, the P2X3 purinoceptor and IB4 binding sites. Eur. J. Neurosci. (1999) 11:946-958.
   PubMed Web of Science ®Google Scholar
• ICHIKAWA H, SUGIMOTO T: VR1-immunoreactive primary sensory neurons in the rat trigeminal ganglion. Brain Res (2001) 890:184-188.
   PubMed Web of Science ®Google Scholar
• MICHAEL GJ, PRIESTLEY JV: Differential expression of the mRNA for the vanilloid receptor subtype 1 in cells of the adult rat dorsal root and nodose ganglia and its downregulation by axotomy. J. Neurosci. (1999) 19:1844-1854.
   PubMed Web of Science ®Google Scholar
• AVELINO A, CRUZ C, NAGY I, CRUZ F: Vanilloid receptor 1 expression in the rat urinary tract. Neuroscience (2002) 109:787-798.
   PubMed Web of Science ®Google Scholar
• WARD SM, BAYGUINOV J, WON KJ, GRUNDY D, BERTHOUD HR: Distribution of the vanilloid receptor (VR1) in the gastrointestinal tract. J. Comp. Neurol. (2003) 465:121-135.
   PubMed Web of Science ®Google Scholar
• JI RR, SAMAD TA, JIN SX, SCHMOLL R, WOOLF CJ: p38 MAPK activation by NGF in primary sensory neurons after inflammation increases TRPV1 levels and maintains heat hyperalgesia. Neuron (2002) 36:57-68.
   PubMed Web of Science ®Google Scholar
• AMAYA F, OH-HASHI K, NARUSE Y et al.: Local inflammation increases vanilloid receptor 1 expression within distinct subgroups of DRG neurons. Brain Res. (2003) 963:190-196.
   PubMed Web of Science ®Google Scholar
• CARLTON SM, COGGESHALL RE: Peripheral capsaicin receptors increase in the inflamed rat hindpaw: a possible mechanism for peripheral sensitization. Neurosci. Lett. (2001) 310:53-56.
   PubMed Web of Science ®Google Scholar
• ITOH M, TAKASAKI I, ANDOH T, NOJIMA H, TOMINAGA M, KURAISHI Y: Induction by carageenan inflammation of prepronociceptin mRNA in VR1-immunoreactive neurons in rat dorsal root ganglia. Neurosci. Res. (2001) 40:227-233.
   PubMed Web of Science ®Google Scholar
• LUO H, CHENG J, HAN JS, WAN Y: Change of vanilloid receptor 1 expression in dorsal root ganglion and spinal dorsal horn during inflammatory nociception induced by complete Freund’s adjuvant in rats. Neuroreport (2004) 15:655-658.
   PubMed Web of Science ®Google Scholar
• ZHOU Y, WANG Y, ABDELHADY M, MOURAD MS, HASSOUNA MM: Change of vanilloid receptor 1 following neuromodulation in rats with spinal cord injury. J. Surg. Res. (2002) 107:140-144.
   PubMed Web of Science ®Google Scholar
• HUDSON LJ, BEVAN S, WOTHERSPOON G, GENTRY C, FOX A, WINTER J: VR1 protein expression increases in undamaged DRG neurons after partial nerve injury. Eur. J. Neurosci. (2001) 13:2105-2114.
   PubMed Web of Science ®Google Scholar
• RASHID MH, INOUE M, KONDO S, KAWASHIMA T, BAKOSHI S, UEDA H: Novel expression of vanilloid receptor 1 on capsaicin-insensitive fibers accounts for the analgesic effect of capsaicin cream in neuropathic pain. J. Pharmacol. Exp. Ther. (2003) 304:940-948.
   PubMed Web of Science ®Google Scholar
• KANAI Y, NAKAZATO E, FUJIUCHI A, HARA T, IMAI A: Involvement of an increased spinal TRPV1 sensitization through its up-regulation in mechanical allodynia of CCI rats. Neuropharmacology (2005) 49:977-984.
   PubMed Web of Science ®Google Scholar
• LAZZERI M, VANNUCCHI MG, ZARDO C et al.: Immunohistochemical evidence of vanilloid receptor 1 in normal human urinary bladder. Eur. Urol. (2004) 46:792-798.
   PubMedGoogle Scholar
• BIRDER LA, KANAI AJ, DE GROAT WC et al.: Vanilloid receptor expression suggests a sensory role for urinary bladder epithelial cells. Proc. Natl. Acad. Sci. USA (2001) 98:13396-13401.
   PubMed Web of Science ®Google Scholar
• APOSTOLIDIS A, BRADY CM, YIANGOU Y, DAVIS J, FOWLER CJ, ANAND P: Capsaicin receptor TRPV1 in urothelium of neurogenic human bladders and effect of intravesical resiniferatoxin. Urology (2005) 65:400-405.
   PubMed Web of Science ®Google Scholar
• BIRDER LA, NAKAMURA Y, KISS S et al.: Altered urinary bladder function in mice lacking the vanilloid receptor TRPV1. Nat. Neurosci. (2002) 5:856-860.
   PubMed Web of Science ®Google Scholar
• KING BF, KNOWLES ID, BURNSTOCK G, RAMAGE AG: Investigation of the effects of P2 purinoceptor ligands on the micturition reflex in female urethane-anaesthetized rats. Br. J. Pharmacol. (2004) 142:519-530.
   PubMed Web of Science ®Google Scholar
• COCKAYNE DA, DUNN PM, ZHONG Y et al.: P2X2 knockout mice and P2X2/P2X3 double knockout mice reveal a role for the P2X2 receptor subunit in mediating multiple sensory effects of ATP. J. Physiol. (2005) 567:621-639.
   PubMed Web of Science ®Google Scholar
• APOSTOLIDIS A, POPAT R, YIANGOU Y et al.: Decreased sensory receptors P2X3 and TRPV1 in suburothelial nerve fibers following intradetrusor injections of botulinum toxin for human detrusor overactivity. J. Urol. (2005) 174:977-982; discussion 982-973.
   PubMed Web of Science ®Google Scholar
• BIRDER L: Role of the urothelium in bladder function. Scand. J. Urol. Nephrol. Suppl. (2004) (215):48-53.
   Google Scholar
• KIM JC, KIM DB, SEO SI, PARK YH, HWANG TK: Nerve growth factor and vanilloid receptor expression, and detrusor instability, after relieving bladder outlet obstruction in rats. BJU Int. (2004) 94:915-918.
   PubMed Web of Science ®Google Scholar
• BRADY CM, APOSTOLIDIS AN, HARPER M et al.: Parallel changes in bladder suburothelial vanilloid receptor TRPV1 and pan-neuronal marker PGP9.5 immunoreactivity in patients with neurogenic detrusor overactivity after intravesical resiniferatoxin treatment. BJU Int (2004) 93:770-776.
   PubMed Web of Science ®Google Scholar
• CRUZ F: Mechanisms involved in new therapies for overactive bladder. Urology (2004) 63:65-73.
   PubMedGoogle Scholar
• SILVA C, SILVA J, RIBEIRO MJ, AVELINO A, CRUZ F: Urodynamic effect of intravesical resiniferatoxin in patients with neurogenic detrusor overactivity of spinal origin: results of a double-blind randomized placebo-controlled trial. Eur. Urol. (2005) 48:650-655.
   PubMedGoogle Scholar
• SILVA C, RIBEIRO MJ, CRUZ F: The effect of intravesical resiniferatoxin in patients with idiopathic detrusor instability suggests that involuntary detrusor contractions are triggered by C-fiber input. J. Urol. (2002) 168:575-579.
   PubMed Web of Science ®Google Scholar
• SCULPTOREANU A, DE GROAT WC, BUFFINGTON CA, BIRDER LA: Protein kinase C contributes to abnormal capsaicin responses in DRG neurons from cats with feline interstitial cystitis. Neurosci. Lett. (2005) 381:42-46.
   PubMedGoogle Scholar
• WIDDICOMBE JG: Afferent receptors in the airways and cough. Respir. Physiol. (1998) 114:5-15.
   PubMedGoogle Scholar
• REYNOLDS SM, MACKENZIE AJ, SPINA D, PAGE CP: The pharmacology of cough. Trends Pharmacol. Sci. (2004) 25:569-576.
   PubMed Web of Science ®Google Scholar
• RAMSEY IS, DELLING M, CLAPHAM DE: An introduction to TRP channels. Ann. Rev Physiol (2005) 68:619-647.
   Google Scholar
• KEDEI N, SZABO T, LILE JD et al.: Analysis of the native quaternary structure of vanilloid receptor 1. J. Biol. Chem. (2001) 276:28613-28619.
   PubMedGoogle Scholar
• SMITH GD, GUNTHORPE MJ, KELSELL RE et al.: TRPV3 is a temperature-sensitive vanilloid receptor-like protein. Nature (2002) 418:186-190.
   PubMed Web of Science ®Google Scholar
• JORDT SE, JULIUS D: Molecular basis for species-specific sensitivity to ‘hot’ chili peppers. Cell (2002) 108:421-430.
   PubMed Web of Science ®Google Scholar
• PHILLIPS E, REEVE A, BEVAN S, MCINTYRE P: Identification of species-specific determinants of the action of the antagonist capsazepine and the agonist PPAHV on TRPV1. J. Biol. Chem. (2004) 279:17165-17172.
   PubMedGoogle Scholar
• SUTTON KG, GARRETT EM, RUTTER AR, BONNERT TP, JAROLIMEK W, SEABROOK GR: Functional characterisation of the S512Y mutant vanilloid human TRPV1 receptor. Br. J. Pharmacol. (2005) 146:702-711.
   PubMedGoogle Scholar
• GAVVA NR, KLIONSKY L, QU Y et al.: Molecular determinants of vanilloid sensitivity in TRPV1. J. Biol. Chem. (2004) 279:20283-20295.
   PubMed Web of Science ®Google Scholar
• JORDT SE, TOMINAGA M, JULIUS D: Acid potentiation of the capsaicin receptor determined by a key extracellular site. Proc. Natl. Acad. Sci. USA (2000) 97:8134-8139.
   PubMed Web of Science ®Google Scholar
• SMART D, GUNTHORPE MJ, JERMAN JC et al.: The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1). Br. J. Pharmacol. (2000) 129:227-230.
   PubMed Web of Science ®Google Scholar
• HUANG SM, BISOGNO T, TREVISANI M et al.: An endogenous capsaicin-like substance with high potency at recombinant and native vanilloid VR1 receptors. Proc. Natl. Acad. Sci. USA (2002) 99:8400-8405.
   PubMed Web of Science ®Google Scholar
• CHU CJ, HUANG SM, DE PETROCELLIS L et al.: N-oleoyldopamine, a novel endogenous capsaicin-like lipid that produces hyperalgesia. J. Biol. Chem. (2003) 278:13633-13639.
   PubMed Web of Science ®Google Scholar
• SHIN J, CHO H, HWANG SW et al.: Bradykinin-12-lipoxygenase-VR1 signaling pathway for inflammatory hyperalgesia. Proc. Natl. Acad. Sci. USA (2002) 99:10150-10155.
   PubMed Web of Science ®Google Scholar
• VENNEKENS R, VOETS T, BINDELS RJ, DROOGMANS G, NILIUS B: Current understanding of mammalian TRP homologues. Cell Calcium (2002) 31:253-264.
   PubMedGoogle Scholar
• CHUANG HH, PRESCOTT ED, KONG H et al.: Bradykinin and nerve growth factor release the capsaicin receptor from PtdIns(4,5)P2-mediated inhibition. Nature (2001) 411:957-962.
   PubMed Web of Science ®Google Scholar
• ROSENBAUM T, GORDON-SHAAG A, MUNARI M, GORDON SE: Ca2+/calmodulin modulates TRPV1 activation by capsaicin. J. Gen. Physiol. (2004) 123:53-62.
   PubMedGoogle Scholar
• NUMAZAKI M, TOMINAGA T, TAKEUCHI K, MURAYAMA N, TOYOOKA H, TOMINAGA M: Structural determinant of TRPV1 desensitization interacts with calmodulin. Proc. Natl. Acad. Sci. USA (2003) 100:8002-8006.
   PubMed Web of Science ®Google Scholar
• WANG Y, KEDEI N, WANG M et al.: Interaction between protein kinase Cmu and the vanilloid receptor Type 1. J. Biol. Chem. (2004) 279:53674-53682.
   PubMed Web of Science ®Google Scholar
• BONNINGTON JK, MCNAUGHTON PA: Signalling pathways involved in the sensitisation of mouse nociceptive neurones by nerve growth factor. J. Physiol. (2003) 551:433-446.
   PubMed Web of Science ®Google Scholar
• TOMINAGA M, WADA M, MASU M: Potentiation of capsaicin receptor activity by metabotropic ATP receptors as a possible mechanism for ATP-evoked pain and hyperalgesia. Proc. Natl. Acad. Sci. USA (2001) 98:6951-6956.
   PubMed Web of Science ®Google Scholar
• SUGIURA T, TOMINAGA M, KATSUYA H, MIZUMURA K: Bradykinin lowers the threshold temperature for heat activation of vanilloid receptor 1. J. Neurophysiol. (2002) 88:544-548.
   PubMedGoogle Scholar
• AMADESI S, NIE J, VERGNOLLE N et al.: Protease-activated receptor 2 sensitizes the capsaicin receptor transient receptor potential vanilloid receptor 1 to induce hyperalgesia. J. Neurosci. (2004) 24:4300-4312.
   PubMed Web of Science ®Google Scholar
• DAI Y, MORIYAMA T, HIGASHI T et al.: Proteinase-activated receptor 2-mediated potentiation of transient receptor potential vanilloid subfamily 1 activity reveals a mechanism for proteinase-induced inflammatory pain. J. Neurosci. (2004) 24:4293-4299.
   PubMed Web of Science ®Google Scholar
• ZHANG N, INAN S, COWAN A et al.: A proinflammatory chemokine, CCL3, sensitizes the heat- and capsaicin-gated ion channel TRPV1. Proc. Natl. Acad. Sci. USA (2005) 102:4536-4541.
   PubMed Web of Science ®Google Scholar
• SUGIUAR T, BIELEFELDT K, GEBHART GF: TRPV1 function in mouse colon sensory neurons is enhanced by metabotropic 5-hydroxytryptamine receptor activation. J. Neurosci. (2004) 24:9521-9530.
   PubMedGoogle Scholar
• CRANDALL M, KWASH J, YU W, WHITE G: Activation of protein kinase C sensitizes human VR1 to capsaicin and to moderate decreases in pH at physiological temperatures in Xenopus oocytes. Pain (2002) 98:109-117.
   PubMedGoogle Scholar
• VELLANI V, MAPPLEBECK S, MORIONDO A, DAVIS JB, MCNAUGHTON PA: Protein kinase C activation potentiates gating of the vanilloid receptor VR1 by capsaicin, protons, heat and anandamide. J. Physiol. (2001) 534:813-825.
   PubMed Web of Science ®Google Scholar
• BHAVE G, HU HJ, GLAUNER KS et al.: Protein kinase C phosphorylation sensitizes but does not activate the capsaicin receptor transient receptor potential vanilloid 1 (TRPV1). Proc. Natl. Acad. Sci. USA (2003) 100:12480-12485.
   PubMed Web of Science ®Google Scholar
• CORRELL CC, PHELPS PT, ANTHES JC, UMLAND S, GREENFEDER S: Cloning and pharmacological characterization of mouse TRPV1. Neurosci. Lett (2004) 370:55-60.
   PubMed Web of Science ®Google Scholar
• MANDADI S, NUMAZAKI M, TOMINAGA M, BHAT MB, ARMATI PJ, ROUFOGALIS BD: Activation of protein kinase C reverses capsaicin-induced calcium-dependent desensitization of TRPV1 ion channels. Cell Calcium (2004) 35:471-478.
   PubMed Web of Science ®Google Scholar
• PREMKUMAR LS, AHERN GP: Induction of vanilloid receptor channel activity by protein kinase C. Nature (2000) 408:985-990.
   PubMed Web of Science ®Google Scholar
• OLAH Z, KARAI L, IADAROLA MJ: Protein kinase C(alpha) is required for vanilloid receptor 1 activation. Evidence for multiple signaling pathways. J. Biol. Chem. (2002) 277:35752-35759.
   PubMed Web of Science ®Google Scholar
• BOLCSKEI K, HELYES Z, SZABO A et al.: Investigation of the role of TRPV1 receptors in acute and chronic nociceptive processes using gene-deficient mice. Pain (2005) 117:368-376.
   PubMed Web of Science ®Google Scholar
• BEVAN S, HOTHI S, HUGHES G et al.: Capsazepine: a competitive antagonist of the sensory neurone excitant capsaicin. Br. J. Pharmacol. (1992) 107:544-552.
   PubMed Web of Science ®Google Scholar
• WALPOLE CS, BEVAN S, BOVERMANN G et al.: The discovery of capsazepine, the first competitive antagonist of the sensory neuron excitants capsaicin and resiniferatoxin. J. Med. Chem. (1994) 37:1942-1954.
   PubMed Web of Science ®Google Scholar
• JENNINGS EA, VAUGHAN CW, ROBERTS LA, CHRISTIE MJ: The actions of anandamide on rat superficial medullary dorsal horn neurons in vitro. J. Physiol. (2003) 548:121-129.
   PubMedGoogle Scholar
• SAVIDGE JR, RANASINGHE SP, RANG HP: Comparison of intracellular calcium signals evoked by heat and capsaicin in cultured rat dorsal root ganglion neurons and in a cell line expressing the rat vanilloid receptor, VR1. Neuroscience (2001) 102:177-184.
   PubMedGoogle Scholar
• MCINTYRE P, MCLATCHIE LM, CHAMBERS A et al.: Pharmacological differences between the human and rat vanilloid receptor 1 (VR1). Br. J. Pharmacol. (2001) 132:1084-1094.
   PubMed Web of Science ®Google Scholar
• WALKER KM, URBAN L, MEDHURST SJ et al.: The VR1 antagonist capsazepine reverses mechanical hyperalgesia in models of inflammatory and neuropathic pain. J. Pharmacol. Exp. Ther. (2003) 304:56-62.
   PubMed Web of Science ®Google Scholar
• VALENZANO KJ, GRANT ER, WU G et al.: BCTC (N-(4-tertiarybutylphenyl)-4- (3-chloropyridin-2-yl) tetrahydropyrazine-1 (2H)-carbox-amide), a novel, orally- effective vanilloid receptor 1 antagonist with analgesic properties: I. In vitro characterization and pharmacokinetic properties. J. Pharmacol. Exp. Ther. (2003) 306(1):377-386.
   PubMed Web of Science ®Google Scholar
• POMONIS JD, HARRISON JE, MARK L, BRISTOL DR, VALENZANO KJ, WALKER K: BCTC (N-(4-tertiarybutylphenyl)-4-(3-cholorpyridin-2-yl) tetrahydropyrazine-1(2H) -carbox-amide), a novel, orally- effective vanilloid receptor 1 antagonist with analgesic properties: II. In vivo characterization in rat models of inflammatory and neuropathic pain. J. Pharmacol. Exp. Ther. (2003) 306(1):387-393.
   PubMed Web of Science ®Google Scholar
• SAVIDGE J, DAVIS C, SHAH K et al.: Cloning and functional characterization of the guinea pig vanilloid receptor 1. Neuropharmacology (2002) 43:450-456.
   PubMed Web of Science ®Google Scholar
• SWANSON DM, DUBIN AE, SHAH C et al.: Identification and biological evaluation of 4-(3-trifluoromethylpyridin- 2-yl)piperazine-1-carboxylic acid (5-trifluoromethylpyridin-2-yl)amide, a high affinity TRPV1 (VR1) vanilloid receptor antagonist. J. Med. Chem. (2005) 48:1857-1872.
   PubMed Web of Science ®Google Scholar
• EL KOUHEN R, SUROWY CS, BIANCHI BR et al.: A-425619 [1-isoquinolin-5-yl-3-(4-trifluoromethyl-benzyl)-urea], a novel and selective transient receptor potential Type V1 receptor antagonist, blocks channel activation by vanilloids, heat, and acid. J. Pharmacol. Exp. Ther. (2005) 314:400-409.
   PubMed Web of Science ®Google Scholar
• HONORE P, WISMER CT, MIKUSA J et al.: A-425619 [1-isoquinolin-5-yl-3- (4-trifluoromethyl-benzyl)-urea], a novel transient receptor potential Type V1 receptor antagonist, relieves pathophysiological pain associated with inflammation and tissue injury in rats. J. Pharmacol. Exp. Ther. (2005) 314:410-421.
   PubMed Web of Science ®Google Scholar
• GUNTHORPE MJ, RAMI HK, JERMAN JC et al.: Identification and characterisation of SB-36 6791, a potent and selective vanilloid receptor (VR1/TRPV1) antagonist. Neuropharmacology (2004) 46:133-149.
   PubMed Web of Science ®Google Scholar
• GAVVA NR, TAMIR R, QU Y et al.: AMG 9810 [(E)-3-(4-t-butylphenyl)-N-(2,3-di hydrobenzo[b][1,4] dioxin-6-yl)acryl amide], a novel vanilloid receptor 1 (TRPV1) antagonist with antihyperalgesic properties. J. Pharmacol. Exp. Ther. (2005) 313:474-484.
   PubMed Web of Science ®Google Scholar
• CULSHAW AJ, BEVAN S, CHRISTIANSEN M et al.: Identification and biological characterization of 6-aryl-7-isopropylquinazolinones as novel TRPV1 antagonists that are effective in models of chronic pain. J. Med. Chem. (2006) 49:471-474.
   PubMed Web of Science ®Google Scholar
• SZELENYI Z, HUMMEL Z, SZOLCSANYI J, DAVIS JB: Daily body temperature rhythm and heat tolerance in TRPV1 knockout and capsaicin pretreated mice. Eur. J. Neurosci. (2004) 19:1421-1424.
   PubMed Web of Science ®Google Scholar
• IIDA T, SHIMIZU I, NEALEN ML, CAMPBELL A, CATERINA M: Attenuated fever response in mice lacking TRPV1. Neurosci. Lett. (2005) 378:28-33.
   PubMed Web of Science ®Google Scholar